
Keywords: متابولیسم آرژنین; arginine metabolism; cardio-oncology; cardiotoxicity; doxorubicin; nitrosative stress; trastuzumab; ADMA; asymmetric dimethylarginine; BMI; body mass index; CI; confidence interval; CTRCD; cancer therapeutics-related cardiac dysfunction; IQR; interquart